Loading provider…
Loading provider…
Internal Medicine Physician in Houston, TX
NPI: 1144470758Primary Employer
Physicians Referral Service
mdanderson.org
HQ Phone
Mobile
Get M.D. Hans's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardMO State Medical License
TX State Medical License
FL State Medical License
2021
AZ State Medical License
2022 - 2026
TX State Medical License
2012 - 2026
AL State Medical License
2022 - 2025
GA State Medical License
2022 - 2025
LA State Medical License
2022 - 2025
MS State Medical License
2022 - 2025
NM State Medical License
2021 - 2025
OK State Medical License
2020 - 2025
TN State Medical License
2022 - 2025
WA State Medical License
2022 - 2025
MO State Medical License
2010 - 2012

American Board of Internal Medicine
Hematology

American Board of Internal Medicine
Medical Oncology
Indiana University School Of Medicine
medicine.iu.edu
Medical School
Until 2008
University of Texas Health Science Center at Houston/M D Anderson Cancer Center
Fellowship • Hematology and Medical Oncology
2011 - 2014
Washington University/B-JH/SLCH Consortium
Residency • Internal Medicine
2008 - 2011
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99214Established patient office or other outpatient visit, 30-39 minutes | 222 | 513 |
| 2 | 99215Established patient office or other outpatient, visit typically 40 minutes | 65 | 126 |
| 3 | 99233Subsequent hospital inpatient care, typically 35 minutes per day | 48 | 174 |
| 4 | 99442Physician telephone patient service, 11-20 minutes of medical discussion | 39 | 71 |
| 5 | 99239Hospital discharge day management, more than 30 minutes | 31 | 33 |
Authors: Lee, Hans C, Raje, Noopur S, Landgren, Ola, Upreti, Vijay V, Wang, Jin, Avilion, Ariel A, Hu, Xuguang, Rasmussen, Erik, Ngarmchamnanrith, Gataree, Fujii, Hisaki, Spencer, Andrew
Journal: Leukemia
Publication Date: 2020-04-21
Impact of clonal plasma cells in autografts on outcomes in high-risk multiple myeloma patients.
Authors: Adeel Masood, Elizabeth Shpall, Pei Lin, Jeremy Ramdial, Krina Patel, Guilin Tang, Robert Orlowski, Sassine Ghanem, Sheeba Thomas, Partow Kebriaei, Paul Lin, Qaiser Bashir, Richard Champlin, Donna Weber, Muzaffar Qazilbash, Oren Pasvolsky, Yago Nieto, Paul Lin, Ali Mohamedi, Neeraj Saini
Publication Date:
Lead Sponsor: Takeda
Intervention / Treatment: DRUG: Lenalidomide, DRUG: Daratumumab, DRUG: Pomalidomide, DRUG: Bortezomib, DRUG: Carfilzomib, DRUG: Modakafusp alfa
Lead Sponsor: M.D. Anderson Cancer Center
Collaborators: Takeda
Intervention / Treatment: DRUG: Dexamethasone, OTHER: Quality-of-Life Assessment, DRUG: Bortezomib, BIOLOGICAL: Daratumumab, DRUG: Ixazomib
Lead Sponsor: M.D. Anderson Cancer Center
Collaborators: Takeda, Janssen Pharmaceuticals
Intervention / Treatment: DRUG: Dexamethasone, BIOLOGICAL: Daratumumab, DRUG: Ixazomib